Anexo: Estudios clínicos Ip6 con Inositol

ESTUDIOS CLÍNICOS DE IP6 CON INOSITOL

(72)
Anticancer Res. 1999 Sep-Oct;19(5A):3733-6.

Metabolism and cellular functions of IP6: a review.

Shamsuddin AM.

Source

Department of Pathology, University of Maryland at Baltimore, USA

Fuente: http://www.ncbi.nlm.nih.gov/pubmed/10625949

(73)

Anticancer Res. 1999 Sep-Oct;19(5A):3699-702.

Inositol hexaphosphate (IP6) as an anti-neoplastic and lipid-lowering agent.

Jariwalla RJ.

Source

California Institute for Medical Research, Santa Clara Valley Medical Center, San Jose 95128, USA.

Fuente: http://www.ncbi.nlm.nih.gov/pubmed/10625943

*(74)

Anticancer Res. 1999 Sep-Oct;19(5A):3671-4.

Mammary tumor inhibition by IP6: a review.

Shamsuddin AM, Vucenik I.

Source

Department of Pathology, University of Maryland School of Medicine, Baltimore 21201, USA.

Fuente:http://www.ncbi.nlm.nih.gov/pubmed/10625937

Posted in: Estudios, Ip6 con inositol